-
1
-
-
55249090388
-
Gastrointestinal neuroendocrine tumors: Pancreatic endocrine tumors
-
Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology 2008;135:1469-92.
-
(2008)
Gastroenterology
, vol.135
, pp. 1469-1492
-
-
Metz, D.C.1
Jensen, R.T.2
-
2
-
-
29144482046
-
Prognostic factors and survival in endocrine tumor patients: Comparison between gastrointestinal and pancreatic localization
-
Panzuto F, Nasoni S, Falconi M, et al. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization. Endocr Relat Cancer 2005;12:1083-92.
-
(2005)
Endocr Relat Cancer
, vol.12
, pp. 1083-1092
-
-
Panzuto, F.1
Nasoni, S.2
Falconi, M.3
-
3
-
-
55849088735
-
Neuroendocrine tumor epidemiology: Contrasting Norway and North America
-
Hauso O, Gustafsson BI, Kidd M, et al. Neuroendocrine tumor epidemiology: contrasting Norway and North America. Cancer 2008;113:2655-64.
-
(2008)
Cancer
, vol.113
, pp. 2655-2664
-
-
Hauso, O.1
Gustafsson, B.I.2
Kidd, M.3
-
4
-
-
37449029464
-
Gastroenteropancreatic neuroendocrine tumours
-
Modlin IM, Oberg K, Chung DC, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008;9:61-72.
-
(2008)
Lancet Oncol
, vol.9
, pp. 61-72
-
-
Modlin, I.M.1
Oberg, K.2
Chung, D.C.3
-
5
-
-
77955660968
-
Incidence rates of exocrine and endocrine pancreatic cancers in the United States
-
Zhou J, Enewold L, Stojadinovic A, et al. Incidence rates of exocrine and endocrine pancreatic cancers in the United States. Cancer Causes Control 2010;21:853-61.
-
(2010)
Cancer Causes Control
, vol.21
, pp. 853-861
-
-
Zhou, J.1
Enewold, L.2
Stojadinovic, A.3
-
6
-
-
70350442637
-
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: A report from the PROMID Study Group
-
Rinke A, Müller HH, Schade-Brittinger C, et al. Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. J Clin Oncol 2009;27:4656-63.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4656-4663
-
-
Rinke, A.1
Müller, H.H.2
Schade-Brittinger, C.3
-
8
-
-
79851500081
-
Everolimus for advanced pancreatic neuroendocrine tumors
-
Yao JC, Shah MH, Ito T, et al. Everolimus for advanced pancreatic neuroendocrine tumors. N Engl J Med 2011;364:514-23.
-
(2011)
N Engl J Med
, vol.364
, pp. 514-523
-
-
Yao, J.C.1
Shah, M.H.2
Ito, T.3
-
9
-
-
74949122343
-
Pancreatic endocrine tumors: Expression profiling evidences a role for AKT-mTOR pathway
-
Missiaglia E, Dalai I, Barbi S, et al. Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol 2010;28:245-55.
-
(2010)
J Clin Oncol
, vol.28
, pp. 245-255
-
-
Missiaglia, E.1
Dalai, I.2
Barbi, S.3
-
10
-
-
79851482955
-
Sunitinib malate for the treatment of pancreatic neuroendocrine tumors
-
Raymond E, Dahan L, Raoul J-L, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 2011;364:501-13.
-
(2011)
N Engl J Med
, vol.364
, pp. 501-513
-
-
Raymond, E.1
Dahan, L.2
Raoul, J.-L.3
|